News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemagen Diagnostics, Inc. (HMGN) Announces Gain On Sale Of Baltimore Property, Books Approximately $1 Million In Cash On Balance Sheet



7/31/2006 11:50:11 AM

COLUMBIA, Md.--(BUSINESS WIRE)--July 31, 2006--Hemagen Diagnostics, Inc. (OTC:HMGN.OB - News) a biotechnology company that develops, manufactures, and markets more than 150 FDA-cleared proprietary medical diagnostic test kits, today announced the sale of a manufacturing building that was purchased in June 2005. The building was purchased for $800,000 plus regular and customary expenses and was sold in July 2006 for $1,800,000, less expenses. As a result of the sale, the Company will record a gain in the fourth quarter of 2006.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES